BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34082608)

  • 61. Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics.
    Cai K; Xie Z; Liu Y; Wu J; Song H; Liu W; Wang X; Xiong Y; Gan S; Sun Y
    Biomed Res Int; 2023; 2023():2152432. PubMed ID: 36714024
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential genes and pathways associated with heterotopic ossification derived from analyses of gene expression profiles.
    Yang Z; Liu D; Guan R; Li X; Wang Y; Sheng B
    J Orthop Surg Res; 2021 Aug; 16(1):499. PubMed ID: 34389038
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comprehensive bioinformatics analysis to identify a candidate prognostic biomarker for ovarian cancer.
    Zhu H; Yue H; Xie Y; Du Q; Chen B; Zhou Y; Liu W
    Transl Cancer Res; 2021 Mar; 10(3):1537-1548. PubMed ID: 35116478
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.
    Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S
    Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
    Zhang M; Luo SC
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.
    Yan HB; Zhang Y; Cen JM; Wang X; Gan BL; Huang JC; Li JY; Song QH; Li SH; Chen G
    Med Sci Monit; 2018 Jul; 24():4807-4822. PubMed ID: 29997385
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CAV1 and KRT5 are potential targets for prostate cancer.
    Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
    Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms.
    Guo T; Hou D; Yu D
    Mol Med Rep; 2019 Nov; 20(5):4415-4424. PubMed ID: 31545495
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Study on potential differentially expressed genes in stroke by bioinformatics analysis.
    Yang X; Wang P; Yan S; Wang G
    Neurol Sci; 2022 Feb; 43(2):1155-1166. PubMed ID: 34313877
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods.
    He Z; Duan X; Zeng G
    PeerJ; 2019; 7():e7872. PubMed ID: 31598425
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer.
    Chen F; Wang Y; Zhang X; Fang J
    Gene; 2023 Jan; 851():146942. PubMed ID: 36202277
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Role of Long Non-coding RNA Prostate Cancer-Associated Transcript 1 in Prostate Cancer.
    Yang Y; Yang W; Jin L
    J Comput Biol; 2019 Sep; 26(9):975-984. PubMed ID: 31090454
    [No Abstract]   [Full Text] [Related]  

  • 78. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
    Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
    Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.